Document:

Exhibit
10.10

 

FIRST
AMENDMENT TO

LIFEMD,
INC.

2020
EQUITY AND INCENTIVE PLAN

 

WHEREAS,
LifeMD, Inc. (formerly Conversion Labs, Inc. the “Company”) desires to amend the LifeMD, Inc. 2020 Equity and
Incentive Plan to increase the aggregate number authorized for issuance under the Plan by 1,500,000 shares of common stock, $0.01 par
value per share, of the Company (the “Common Stock”) (the “Plan Amendment”); and

 

WHEREAS,
on April 24, 2021, subject to stockholder approval, the Board of Directors of the Company approved the Plan Amendment.

 

NOW,
THEREFORE, in accordance with Section 11 of the Plan, the Plan is hereby amended as follows:

 

	 	1.	Section
    3 of the Plan is hereby amended by deleting paragraph 3(a) thereof in its entirety and substituting the following in lieu thereof:

 

“(a)
Stock Issuable. The maximum number of Shares reserved and available for issuance under the Plan shall be 3,000,000 Shares (the
“Share Reserve”), subject to adjustment as provided in Section 3(b) and the following sentence regarding the annual increase.
In addition, the Share Reserve will automatically increase on January 1st of each year, for a period of not more than ten years, commencing
on January 1, 2021 and ending on (and including) January 1, 2030, in an amount equal to 150,000shares. Notwithstanding the foregoing,
the Board may act prior to January 1st of a given year to provide that there will be no January 1st increase in the Share Reserve for
such year or that the increase in the Share Reserve for such year will be a lesser number of shares of Stock than would otherwise occur
pursuant to the preceding sentence. If a Stock Award or any portion thereof (i) expires or otherwise terminates without all of the shares
covered by such Stock Award having been issued or (ii) is settled in cash (i.e., the Participant receives cash rather than stock), the
Shares subject to such Stock Award, to the extent of any such expiration, termination or settlement, will again be available for issuance
under the Plan. If any shares of Stock issued pursuant to a Stock Award are forfeited back to or repurchased by the Company because of
the failure to meet a contingency or condition required to vest such shares in the Participant, then the shares that are forfeited or
repurchased will revert to and again become available for issuance under the Plan. Any shares reacquired by the Company in satisfaction
of tax withholding obligations on a Stock Award or as consideration for the exercise or purchase price of a Stock Award will again become
available for issuance under the Plan. For purposes of this limitation, the Shares underlying any Awards that are forfeited, canceled,
reacquired by the Company prior to vesting, satisfied without the issuance of Stock or otherwise terminated (other than by exercise)
shall be added back to the Shares available for issuance under the Plan. Subject to such overall limitations, Shares may be issued up
to such maximum number pursuant to any type or types of Award, and no more than 200,000 Shares may be issued pursuant to Incentive Stock
Options. The value of any Shares granted to a non-employee director of the Company, solely for services as a director, when added to
any annual cash payments or awards, shall not exceed an aggregate value of two hundred thousand dollars ($200,000) in any calendar year.

 

	 	2.	The
    Plan Amendment shall be effective upon approval of the stockholders of the Company at the 2021 Annual Meeting of Stockholders. If
    the Plan Amendment is not so approved at such meeting, then the amendment to the Plan set forth herein shall be void ab initio.

 

	 	3.	Except
    herein provided, the Plan is hereby ratified, confirmed and approved in all respects.Exhibit
10.11

 

SECOND
Amendment to the AMENDED and RESTATED EMPLOYMENT Agreement 

 

This
SECOND Amendment to the amended and restated EMPLOYMENT Agreement (this
“Second Amendment”) is entered into as of June 29, 2021 (the “Second Amendment Effective Date”) by and between
Brad Roberts, an individual and resident of the State of South Carolina, (the “Employee”) and LifeMD, Inc. (formerly known
as Conversion Labs, Inc.), (the “Company”), a Delaware Corporation. The Employee and the Company are also each hereinafter
referred to individually as a “Party” and together as the “Parties”.

 

RECITALS

 

WHEREAS,
on December 21, 2020 (“Effective Date”), the Company and the Employee entered into an Amended and Restated Employment Agreement
(the “Amended and Restated Employment Agreement”) whereby Employee was hired to serve the Company in the capacity as Chief
Operating Officer;

 

WHEREAS,
on June 15, 2021, the Company and the Employee entered into a First Amendment To The Amended and Restated Employment Agreement (the “First
Amendment”) wherein Employee’s Base Salary was increased and the terms concerning the Annual Bonus were updated, as described
in more detail therein.

 

WHEREAS,
for avoidance of doubt, other than the amendments set forth beow in this Second Amendment and those set forth in the First Amendment,
all other provisions of the Amended and Restated Employment remain in effect today and moving further, unless and until amended in the
future.

 

WHEREAS,
the Parties desire to further amend the Amended and Restated Employment Agreement to: (i) further define factors considered in determining
whether to award a discretionary Annual Bonus; and (ii) add a long term equity incentive provision.

 

NOW
THEREFORE, for good and valuable consideration, the receipt of which is hereby acknowledged, the Parties hereby agree as follows:

 

1.       Amendments.
The Amended and Restated Employment Agreement shall be further amended as follows, in accordance with the terms and conditions of Section
7 thereof:

 

    	1

    	 

    

 

		a.	Section
                                            4(e) of the Amended and Restated Employment Agreement is hereby added:

 

(e)       Long
Term Equity Incentive. Employee shall be granted three hundred (300,000) restricted stock units (the “RSUs”) under and
subject to all of the provisions of a related award agreement (the “RSU Award Agreement”), upon and subject to approval by
the Company’s Board of Directors (the “Board”). The RSUs will be unvested on the grant date. The Restricted Shares
will be issued in such amounts and upon the Company’s Telemedicine Brands achieving certain revenue milestones (each a “Milestone”)
in accordance with the SCHEDULE FOR RESTRICTED SHARE GRANT provide below. RSUs, if, and to the extent, issued and when issued, will vest
on the achievement of each Milestone. “Telemedicine Brand” shall be defined as any brand owned by the Company that provides
virtual medical treatment or sells any prescription medication. Except as otherwise set forth herein or in the RSU Award Agreement, vesting
of the RSUs will cease upon the termination of Employee’s employment with the Company subject to the terms of Section 5 below.
In addition, all of the RSUs, if, and to the extent, issued and when issued, will vest immediately upon a Change of Control. As used
herein, “Change of Control” means (i) a bona fide transfer or series of related transfers of Shares to any person or Group
in which, or as a result of which, such person or Group obtains the direct or indirect right to elect a majority of the board of directors
of the Company; or (ii) a sale of all or substantially all of the assets of the Company. As used herein, “Group” means any
group or syndicate that would be considered a “person” for purposes of Section 13(d) of the Securities Exchange Act of 1934,
as amended.

 

Schedule
For Restricted Share Grant:

 

Up
to 300,000 RSUs vesting on upon achieving each of the following Milestones in connection with the Company’s Net Sales of its Telemedicine
Brands. Net sales means the sum of a company’s gross sales minus its returns and chargebacks.

 

	Number
    of Shares Vested	 	 
Revenue
                                            Milestone

	150,000	 	$100,000,000 in Net Sales in any calendar year
	150,000	 	$200,000,000 in Net Sales in any calendar year

 

2.       Governing
Law; Jurisdiction. This Second Amendment shall be governed by and construed in accordance with the internal laws of the State of
New York without giving effect to any choice or conflict of law provision or rule (whether of the State of New York or any other jurisdiction).
Any legal proceeding arising out of or based upon this Second Amendment shall be instituted in the federal courts or the courts of the
State of New York and each party irrevocably submits to the exclusive jurisdiction of such courts in any such proceeding.

 

3.       Counterparts.
This Second Amendment may be executed in several counterparts, each of which shall be deemed to be an original copy and all of which
together shall constitute one agreement binding on all parties hereto, notwithstanding that all the parties shall not have signed the
same counterpart.

 

[signature
on next page]

 

    	2

    	 

    

 

IN
WITNESS WHEREOF, each of the undersigned hereby (a) executes this Second Amendment to the Amended and Restated Employment Agreement;
(b) confirms its agreement with the provisions and covenants herein provided; and (c) agrees to be bound by this Second Amendment to
the Amended and Restated Employment Agreement.

 

EXECUTED
as of the Second Amendment Effective Date, as set forth above.

 

	LIFEMD,
    INC.	 
	 	 
	 /s/
    Justin Schreiber 	 
	By:
    Justin Schreiber, Chairman & CEO 	 
	 	 
	eMPLOYEE	 
	 	 
	 /s/
    Brad Roberts 	 
	By:
    Brad Roberts, Chief Operating Officer	 

 

    	3Exhibit 10.14

 

Execution
Version

 

LIFEMD,
INC.

NON-QUALIFIED
STOCK OPTION AGREEMENT

 

EMPLOYEE
/ CONTRACTOR

 

THIS
NON-QUALIFIED STOCK OPTION AGREEMENT (the “Agreement”) entered into as of June 10, 2021 (the “Effective Date”),
by and between LifeMD, Inc. (the “Company”) and Alexander Mironov (the “Optionee”).

 

WHEREAS,
pursuant to the authority of the Board of Directors (the “Board”), the Company has granted the Optionee the right
to purchase common stock, $0.01 par value per share (“Common Stock”) of the Company pursuant to stock options, at
not less than 100% of fair market value.

 

NOW
THEREFORE, in consideration of the mutual covenants and promises hereafter set forth and other good and valuable consideration, the receipt
and sufficiency of which is hereby acknowledged, the parties hereto agree as follows:

 

1.
Grant of Non-Qualified Options. The Company hereby irrevocably grants to the Optionee, as a matter of separate agreement and not
in lieu of salary or other compensation for services, the right and option to purchase all or any part of an aggregate of 200,000 shares
of authorized but unissued or treasury common stock of the Company (the “Options”) on the terms and conditions herein
set forth. The Options are not intended to be Incentive Stock Options as defined by Section 422 of the Internal Revenue Code of 1986,
as amended (the “Code”).

 

2.
Price. The exercise price of the shares of Common Stock subject to the Options granted hereunder shall be $14.04.

 

3.
Vesting.

 

(a)
The Options shall vest as follows:

 

(i)
1/36th of the shares subject to the Option shall be fully vested on the Effective Date; and

 

(ii)
subject to the terms herein and the Optionee continuing to perform services for the Company on each applicable vesting dates, the remaining
35/36th of the shares subject to the Option shall vest ratably and become exercisable in equal monthly tranches on the 11th
day of each calendar month, based on the passage of time, over 35 consecutive months, commencing on July 10, 2021.

 

Notwithstanding
the foregoing, the Options shall vest and become exercisable in full upon the termination of the Optionee’s employment or service
with the Company without Cause (if termination is by the Company) or for Good Reason (if termination is by Optionee), as such terms are
defined in the employment or service agreement of such Optionee or if such term or terms is not defined in the employment or service
agreement or there is not an employment or service agreement, as defined in Section 10 of this Agreement. In lieu of fractional vesting,
the number of Options shall be rounded up each time until fractional Options are eliminated.

 

(b)
Subject to Sections 3(c) and 4 of this Agreement, Options may be exercised by providing to the Company the Notice of Option Exercise
in the form attached hereto as Exhibit A after vesting and remain exercisable until 5:30 p.m. New York time on the date that is
the fifth (5th) year anniversary of the date of this Agreement.

 

    	 

     

    

 

(c)
However, notwithstanding any other provision of this Agreement, at the option of the Board in its sole and absolute discretion, all Options
shall be immediately forfeited in the event any of the following events occur:

 

(i)
The Optionee purchases or sells securities of the Company without written authorization in accordance with the Company’s
insider trading policy then in effect, if any;

 

(ii)
The Optionee (A) discloses, publishes or authorizes anyone else to use, disclose or publish, without the prior written consent of
the Company, any proprietary or confidential information of the Company, including, without limitation, any information relating to
existing or potential customers, business methods, financial information, trade or industry practices, sales and marketing
strategies, employee information, vendor lists, business strategies, intellectual property, trade secrets or any other proprietary
or confidential information or (B) directly or indirectly uses any such proprietary or confidential information for the individual
benefit of the Optionee or the benefit of a third party;

 

(iii)
During the term of employment or service and for a period of two (2) years thereafter, the Optionee disrupts or damages, impairs or
interferes with the business of the Company or its Affiliates by recruiting, soliciting or otherwise inducing any of their
respective employees to enter into employment or other relationship with any other business entity, or terminate or materially
diminish their relationship with the Company or its Affiliates, as applicable;

 

(iv)
During the term of employment or service and for a period of one (1) year thereafter, the Optionee solicits or directs business of
any person or entity who is (A) a customer of the Company or its Affiliates at any time or (B) solicited to be a “prospective
customer” of the Company or its Affiliates, in any case either for such Optionee or for any other person or entity. For
purposes of this clause (v), “prospective customer” means a person or entity who contacted, or is contacted by,
the Company or its Affiliates regarding the provision of services to or on behalf of such person or entity; provided that the
Optionee has actual knowledge of such prospective customer;

 

(v)
The Optionee fails to reasonably cooperate to effect a smooth transition of the Optionee’s duties and to ensure that the Company
is apprised of the status of all matters the Optionee is handling or is unavailable for consultation after termination of employment
or service of the Optionee if such availability is a condition of any agreement to which the Company and the Optionee are parties;

 

(vi)
The Optionee fails to assign all of such Optionee’s rights, title and interest in and to any and all ideas, inventions,
formulas, source codes, techniques, processes, concepts, systems, programs, software, computer data bases, trademarks, service
marks, brand names, trade names, compilations, documents, data, notes, designs, drawings, technical data and/or training materials,
including improvements thereto or derivatives therefrom, whether or not patentable or subject to copyright or trademark or trade
secret protection, developed and produced by the Optionee used or intended for use by or on behalf of the Company or the
Company’s clients;

 

(vii)
The Optionee acts in a disloyal manner to the Company, such as making comments, whether oral or in writing, that tend to disparage
or injure (i) the reputation or business of the Company or its Affiliates, or is likely to result in discredit to, or loss of
business, reputation or goodwill of, the Company or its Affiliates or (ii) its directors, officers or stockholders; or

 

(viii)
A finding by the Board that the Optionee has acted against the interests of the Company or in a manner that has or may have a
detrimental effect on the Company.

 

(d)
For purposes of this Agreement, “Affiliate” means with respect to a person or entity, any other person or entity controlled
by, in control of or under common control with such person or entity, and “controlled,” “controlled by,” and
“under common control with” shall mean direct or indirect possession of the power to direct or cause the direction of management
or policies (whether through ownership of voting securities, by contract or otherwise) of a person or entity.

 

    	2

     

    

 

4.
Representations and Warranties; Acknowledgements. In connection with the grant of the Award Shares hereunder, Optionee represents
and warrants to the Company that:

 

(a)
Optionee is able to bear the economic risk of Optionee’s investment in the Shares for an indefinite period of time because the
Award Shares have not been registered under the Securities Act and, therefore, cannot be sold unless subsequently registered under
the Securities Act or an exemption from such registration is available.

 

(b)
Optionee and Optionee’s advisers have had an opportunity to ask questions and receive answers concerning the terms and conditions
of the offering of the Shares as Optionee and Optionee’s advisers have requested and have had full and free access and opportunity
to inspect, review, examine, and inquire about such other information concerning the Company and its subsidiaries as they have requested.
Optionee and Optionee’s advisers have also been provided an opportunity to review and ask questions about the Options.

 

(c)
Optionee has had an opportunity to consult with independent legal counsel regarding Optionee’s rights and obligations under this
Agreement, and fully understands the terms and conditions contained herein. Optionee is not relying on the Company or any of its Optionees,
agents, or representatives with respect to the legal, tax, economic, and related considerations of an investment in the Shares. Optionee
understands that in the future the Shares may significantly increase or decrease in value, and the Company has not made any representation
to the Optionee about the potential future value of the Shares.

 

(d)
Optionee understands and agrees that the investment in the Company involves a high degree of risk and that no guarantees have been made
or can be made with respect to the future value of the Award Shares or the future profitability or success of the Company.

 

5.
Termination of Relationship. Upon Optionee’s termination of service, all unvested Options shall be automatically and irrefutably
forfeited.

 

(a)
If for any reason, except death or disability as provided below, the Optionee ceases to perform the services for which the Options were
granted, the Optionee shall have the right within three (3) months from the date of cessation to exercise the Optionee’s vested
Options, subject to Section 3(c) hereof.

 

(b)
If the Optionee shall die while performing services for the Company, such Optionee’s estate or any Transferee (as defined hereinafter)
shall have the right within twelve (12) months from the date of death to exercise the Optionee’s vested Options, subject to Section
3(c) hereof. For the purpose of this Agreement, “Transferee” shall mean an individual to whom such Optionee’s
vested Options are transferred by will or by the laws of descent and distribution.

 

(c)
If the Optionee shall become disabled while performing services for the Company within the meaning of Section 22(e)(3) of the Code, the
three-month period referred to in Section 5(a) of this Agreement shall be extended to one year.

 

6.
Profits on the Sale of Certain Shares; Redemption. If any of the events specified in Section 3(c) of this Agreement occur within
one (1) year from the last date the Optionee performed services for which the Options were granted (the “Termination Date”),
all profits earned from the sale of the Company’s securities, including the sale of shares of Common Stock underlying the Options,
during the two (2) year period commencing one (1) year prior to the Termination Date shall be forfeited and forthwith paid by the Optionee
to the Company within ten (10) days after the Optionee receives written demand from the Company for such payment and a copy of the documentation
of the sale, including, without limitation, the purchase price therefor. Further, in such event, the Company may at its option redeem
shares of Common Stock acquired upon exercise of the Options by payment of the exercise price to the Optionee. The Company’s rights
under this Section 6 do not lapse one year from the Termination Date, but are a contract right subject to any appropriate statutory limitation
period.

 

    	3

     

    

 

7.
Transfer. No transfer of the Options by the Optionee by will or by the laws of descent and distribution shall be effective to
bind the Company unless the Company shall have been furnished with written notice thereof and a copy of the letters testamentary or such
other evidence as the Board may deem necessary to establish the authority of the estate and the acceptance by the Transferee or Transferees
of the terms and conditions of the Options.

 

8.
Method of Exercise. The Options shall be exercisable by a written notice in the manner and form identified on Exhibit A hereto
which information shall include:

 

(a)
state the election to exercise the Options, the number of shares to be exercised, the natural person in whose name the stock certificate
or certificates for such shares of Common Stock is to be registered and such person’s address and social security number (or if
more than one, the names, addresses and social security numbers of such persons);

 

(b)
contain such representations and agreements as to the holder’s investment intent with respect to such shares of Common Stock as
set forth in Section 12 hereof;

 

(c)
be signed by the person or persons entitled to exercise the Options and, if the Options are being exercised by any person or persons
other than the Optionee, be accompanied by proof, satisfactory to counsel for the Company, of the right of such person or persons to
exercise the Options; and

 

(d)
be accompanied by full payment of the purchase or exercise price and all applicable required tax withholding in United States dollars
in cash or by bank or cashier’s check, certified check or money order or (i) by executing a “sell-to-cover cashless exercise”
through the Company’s designated broker to promptly deliver to the Company the amount of proceeds from the sale of shares having
a fair market value equal to the purchase price and all applicable required tax withholding on the date of exercise; (ii) by executing
a “net cashless exercise” by having the Company withhold Option shares equivalent in value to the exercise price and all
applicable required tax withholding; or (iii) by tendering shares of Common Stock equivalent in value to the exercise price and all applicable
required tax withholding, subject to applicable securities laws and share holding period requirements necessary to avoid a charge to
the Company’s earnings for financial accounting purposes.

 

Any
certificate or certificates for shares of Common Stock as to which the Options shall be exercised shall be registered in the name of
the person or persons exercising the Options.

 

9.
Sale of Shares Acquired Upon Exercise of Options. If the Optionee is an officer (as defined by Section 16(b) of the Securities
Exchange Act of 1934, as amended (“Section 16(b)”), any shares of the Company’s Common Stock acquired pursuant
to Options granted hereunder cannot be sold by the Optionee, subject to registration or an exemption from registration such as to Rule
144 promulgated under the Securities Act of 1933, as amended (the “Securities Act”), until at least six (6) months
elapse from the date of grant of the Options, except in the case of death or disability or if the grant was exempt from the short-swing
profit provisions of Section 16(b).

 

10.
Definitions; Adjustments; Sale Event.

 

(a)
“Cause” shall mean (i) the grantee’s dishonest statements or acts with respect to the Company or any Affiliate of the
Company, or any current or prospective customers, suppliers vendors or other third parties with which such entity does business; (ii)
the grantee’s commission of (A) a felony or (B) any misdemeanor involving moral turpitude, deceit, dishonesty or fraud; (iii) the
grantee’s failure to perform his assigned duties and responsibilities to the reasonable satisfaction of the Company which failure
continues, in the reasonable judgment of the Company, after written notice given to the grantee by the Company; (iv) the grantee’s
gross negligence, willful misconduct or insubordination with respect to the Company or any affiliate of the Company; or (v) the grantee’s
material violation of any provision of any agreement(s) between the grantee and the Company relating to noncompetition, non-solicitation,
non-disclosure and/or assignment of inventions.

 

    	4

     

    

 

(b)
“Good Reason” shall mean (i) a material diminution in the grantee’s base salary except for acrossthe-board salary reductions
similarly affecting all or substantially all similarly situated employees of the Company or (ii) a change of more than 100 miles in the
geographic location at which the grantee provides services to the Company, so long as the grantee provides at least 90 days’ notice
to the Company following the initial occurrence of any such event and the Company fails to cure such event within 30 days thereafter.

 

(c)
Subject to Section 10(d) hereof, if, as a result of any reorganization, recapitalization, reclassification, stock dividend, stock split,
reverse stock split or other similar change in the Company’s capital stock, the outstanding shares of Common Stock are increased
or decreased or are exchanged for a different number or kind of shares or other securities of the Company, or additional shares or new
or different shares or other securities of the Company or other non-cash assets are distributed with respect to such shares or other
securities, in each case, without the receipt of consideration by the Company, or, if, as a result of any merger or consolidation, or
sale of all or substantially all of the assets of the Company, the outstanding shares are converted into or exchanged for other securities
of the Company or any successor entity (or a parent or subsidiary thereof), the Committee shall make an appropriate and proportionate
adjustment in (i) the number and kind of shares or other securities subject to this Agreement, and (ii) the exercise price for each share
subject to this Agreement, without changing the aggregate exercise price (i.e., the exercise price multiplied by the number of Options)
as to which such Options remain exercisable. The Company shall in any event make such adjustments as may be required by the laws of Delaware
and the rules and regulations promulgated thereunder. The adjustment by the Company shall be final, binding and conclusive. No fractional
shares shall be issued resulting from any such adjustment, but the Company in its discretion may make a cash payment in lieu of fractional
shares

 

(d)
In the case of and subject to the consummation of a Sale Event, all outstanding Options issued hereunder shall become one hundred percent
(100%) vested upon the effective time of any such Sale Event. Notwithstanding the foregoing, in the event of a Sale Event, the Company
shall have the right, but not the obligation, to make or provide for a cash payment to the Optionee, without any consent of the Optionee,
in exchange for the cancellation thereof, in an amount equal to the difference between (A) the value as determined by the Company of
the consideration payable per share of Common Stock pursuant to the Sale Event (the “Sale Price”) times the number of shares
subject to outstanding Options being cancelled (to the extent then vested and exercisable, including by reason of acceleration in connection
with such Sale Event, at prices not in excess of the Sale Price) and (B) the aggregate exercise price of all such outstanding vested
and exercisable Options.

 

(e)
“Sale Event” means the consummation of i) a change in the ownership of the Company, ii) a change in effective control of
the Company, or iii) a change in the ownership of a substantial portion of the assets of the Company. The occurrence of a Sale Event
shall be acknowledged by the board of directors, by strictly applying these provisions without any discretion to deviate from the objective
application of the definitions provided herein; provided, however, that any capital raising event, or a merger effected solely to change
the Company’s domicile shall not constitute a “Sale Event.”

 

Except
as otherwise provided herein, a change in the ownership of the Company occurs on the date that any one person, or more than one person
acting as a group acquires ownership of stock of the Company that, together with stock held by such person or group, constitutes more
than 50 percent of the total fair market value or total voting power of the stock of the Company. However, if any one person, or more
than one person acting as a group, is considered to own more than 50 percent of the total fair market value or total voting power of
the stock of the Company the acquisition of additional stock by the same person or persons is not considered to cause a change in the
ownership of the Company (or to cause a change in the effective control of the Company). An increase in the percentage of stock owned
by any one person, or persons acting as a group, as a result of a transaction in which the corporation acquires its stock in exchange
for property will be treated as an acquisition of stock for purposes of this section. This section applies only when there is a transfer
of stock of the Company (or issuance of stock) which remains outstanding after the transaction. A change in the effective control of
the Company occurs only on either of the following dates: (1) The date any one person, or more than one person acting as a group acquires
(or has acquired during the 12-month period ending on the date of the most recent acquisition by such person or persons) ownership of
stock of the Company possessing 30 percent or more of the total voting power of the stock of the Company; (2) The date a majority of
members of the Company’s board of directors is replaced during any 12-month period by directors whose appointment or election is
not endorsed by a majority of the members of the Company’s board of directors before the date of the appointment or election.

 

    	5

     

    

 

A
change in the ownership of a substantial portion of the Company’s assets occurs on the date that any one person, or more than one
person acting as a group acquires (or has acquired during the 12- month period ending on the date of the most recent acquisition by such
person or persons) assets from the Company that have a total gross fair market value equal to or more than 40 percent of the total gross
fair market value of all of the assets of the Company immediately before such acquisition or acquisitions. For this purpose, gross fair
market value means the value of the assets of the corporation, or the value of the assets being disposed of, determined without regard
to any liabilities associated with such assets.

 

11.
Necessity to Become Holder of Record. Neither the Optionee, the Optionee’s estate, nor the Transferee have any rights as
a shareholder with respect to any shares of Common Stock covered by the Options until such Optionee, estate or Transferee, as applicable,
shall have become the holder of record of such shares of Common Stock. No adjustment shall be made for cash dividends or cash distributions,
ordinary or extraordinary, in respect of such shares of Common Stock for which the record date is prior to the date on which such Optionee,
estate or Transferee, as applicable, shall become the holder of record thereof.

 

12.
Conditions to Exercise of Options.

 

(a)
In order to enable the Company to comply with the Securities Act and relevant state law, the Company may require the Optionee, the Optionee’s
estate or any Transferee, as a condition of the exercise of the Options granted hereunder, to give written assurance satisfactory to
the Company that the shares of Common Stock subject to the Options are being acquired for such Optionee’s, estate’s or Transferee’s,
as applicable, own account, for investment only, with no view to the distribution of same, and that any subsequent resale of any such
shares of Common Stock either shall be made pursuant to a registration statement under the Securities Act and applicable state law which
has become effective and is current with regard to the shares of Common Stock being sold, or shall be pursuant to an exemption from registration
under the Securities Act and applicable state law.

 

(b)
The Options are subject to the requirement that, if at any time the Board shall determine, in its sole and absolute discretion, that
the listing, registration or qualification of the shares of Common Stock subject to the Options upon any securities exchange or under
any state or federal law, or the consent or approval of any governmental regulatory body, is necessary as a condition of, or in connection
with the issue or purchase of such shares of Common Stock under the Options, the Options may not be exercised in whole or in part unless
such listing, registration, qualification, consent or approval shall have been effected.

 

13.
Severability. In the event any parts of this Agreement are found to be void, the remaining provisions of this Agreement shall
nevertheless be binding with the same effect as though the void parts were deleted.

 

14.
Arbitration. Any controversy, dispute or claim arising out of or relating to this Agreement, or its interpretation, application,
implementation, breach or enforcement which the parties hereto are unable to resolve by mutual agreement, shall be settled by submission
by either party of the controversy, claim or dispute to binding arbitration in New York County, New York (unless the parties agree in
writing to a different location), before a single arbitrator in accordance with the rules of the American Arbitration Association then
in effect. The decision and award made by the arbitrator shall be final, binding and conclusive on all parties hereto for all purposes,
and judgment may be entered thereon in any court having jurisdiction thereof.

 

15.
Benefit. This Agreement shall be binding upon and inure to the benefit of the parties hereto and their legal representatives,
successors and assigns.

 

    	6

     

    

 

16.
Notices and Addresses. All notices, offers, acceptance and any other acts under this Agreement (except payment) shall be in writing,
and shall be sufficiently given if delivered to the addressees in person, by FedEx or similar receipted delivery, or by facsimile delivery
as follows:

 

	 	The Optionee 	Alexander
    Mironov
	 	 	P.O.
    Box 218
	 	 	Alpine,
    New Jersey 07620
	 	 	Telephone:
    (917) 238-1860
	 	 	 
	 	The Company:	LifeMD,
    Inc.
	 	 	800
    Third Avenue, Suite 2800
	 	 	New
    York, NY 10022
	 	 	Telephone:
    (866) 351-5907

 

or
to such other address as either of them, by notice to the other, may designate from time to time. The transmission confirmation receipt
from the sender’s facsimile machine shall be evidence of successful facsimile delivery. Time shall be counted to, or from, as the
case may be, the delivery in person or by mailing.

 

17.
Attorney’s Fees. In the event that there is any controversy or claim arising out of or relating to this Agreement, or to
the interpretation, breach or enforcement thereof, and any action or proceeding is commenced to enforce the provisions of this Agreement,
the prevailing party shall be entitled from the non-prevailing party to its reasonable attorneys’ fee, costs and expenses.

 

18.
Governing Law. This Agreement and any dispute, disagreement, or issue of construction or interpretation arising hereunder whether
relating to its execution, its validity, the obligations provided herein or performance, shall be governed or interpreted according to
the laws of the State of Delaware without regard to choice of law considerations.

 

19.
Oral Evidence. This Agreement and any amendment thereto, constitute the entire agreement between the parties hereto and supersedes
all prior oral and written agreements between the parties hereto with respect to the subject matter hereof. Neither this Agreement nor
any provision hereof may be changed, waived, discharged or terminated except by a statement in writing signed by the party or parties
against which enforcement or the change, waiver discharge or termination is sought.

 

20.
Counterparts. This Agreement may be executed in one or more counterparts, each of which shall be deemed an original but all of
which together shall constitute one and the same instrument. The execution of this Agreement may be made by facsimile signature, which
shall be deemed to be an original.

 

21.
Section Headings. Section headings herein have been inserted for reference only and shall not be deemed to limit or otherwise
affect, in any matter, or be deemed to interpret in whole or in part, any of the terms or provisions of this Agreement.

 

    	7

     

    

 

IN
WITNESS WHEREOF the parties hereto have set their hand the day and year first above written.

 

	 	LIFEMD,
    INC.
	 	 	 
	 	By:	/s/
    Justin Schreiber
	 	Name:	Justin
    Schreiber
	 	Title:	Chief
    Executive Officer
	 	 	 
	 	OPTIONEE:
	 	 	 
	 	By:	/s/ Alexander Mironov
	 	Name:	Alexander Mironov
	 	Address:	P.O. Box 218
	 		Alpine, New Jersey 07620

 

[Signature
page to Non-qualified Stock Option Agreement]

 

    	8

     

    

 

EXHIBIT
A

 

FORM
OF NOTICE OF OPTION EXERCISE

 

	To:	LifeMD, Inc. (the “Company”)

 

	(1)	The
    undersigned hereby elects to purchase __________ shares of Common Stock of the Company (the “Shares”) pursuant to the
    terms of the Option Agreement by and between the Company and the undersigned dated as of __________ ___, 20__, and tenders herewith
    payment of the exercise price in full as set forth below.
	 	 
	(2)	Payment
    shall take the form of (check applicable box):

 

[  ] in lawful money of the United States in the form of cash or by a bank check or cashier’s check made payable by the undersigned
to the Company;

 

[  ] in lawful money of the United States in the form of a wire transfer to the account specified by the Company;

 

[  ] in the form of shares of a “broker-assisted cashless exercise” as described in Section 8(d) of the Option Agreement;

 

[  ] in the form of shares of a “net cashless exercise” as described in Section 8(d) of the Option Agreement; or

 

[  ] in the form of shares of Common Stock (a “stock-for-stock exercise”) as described in Section 8(d) of the Option Agreement.

 

	(3)	Please
    issue a certificate or certificates representing the Shares in the name of the undersigned or in such other name as is specified
    below:

 

 ____________________________________

 

The
Shares shall be delivered via overnight courier (with tracking information to be provided to the undersigned) to the following address:

 

 ____________________________

 ____________________________

____________________________

Attn:
________________________

Tel:
_________________________

 

	 	OPTIONEE
	 	 
	 	 
	 	 

 

[Exhibit
A to Non-qualified Stock Option Agreement]

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00332-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00332-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00332-of-00352.parquet"}]]